Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-009485

CEO and Chairman sold 30,000 shares at an average $62.31 ($1,869,322)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
ROBINS CHAD M CEO and Chairman 2021-02-08 Sale −7,314 $61.40 $449,080 1,732,466 D
ROBINS CHAD M CEO and Chairman 2021-02-08 Sale −2,686 $62.20 $167,069 1,729,780 D
ROBINS CHAD M CEO and Chairman 2021-02-09 Sale −5,840 $62.07 $362,489 1,723,940 D
ROBINS CHAD M CEO and Chairman 2021-02-09 Sale −4,160 $63.23 $263,037 1,719,780 D
ROBINS CHAD M CEO and Chairman 2021-02-10 Sale −795 $61.51 $48,900 1,718,985 D
ROBINS CHAD M CEO and Chairman 2021-02-10 Sale −6,801 $62.56 $425,471 1,712,184 D
ROBINS CHAD M CEO and Chairman 2021-02-10 Sale −1,204 $63.25 $76,153 1,710,980 D
ROBINS CHAD M CEO and Chairman 2021-02-10 Sale −1,200 $64.27 $77,124 1,709,780 D
Open-market sales · 30,000 sh · avg $62.31 · $1,869,322
Loading xslF345X03/doc4.xml…